Clinical trials recruiting for Major Depressive Episode (MDE)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| TNX-102 SL | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Louisiana | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Nevada | 1 |
| New York | 1 |
| South Carolina | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Belief Update: The Effects of Depression and Antidepressants in Older People
- Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)
- LHC-CIDI-5 in Hong Kong
- Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder
Related conditions
Trials recruiting for Major Depressive Episode (MDE) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Major Depressive Episode (MDE) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.